Skip to main content
Livermore
Livermore
ZHEN

Wulff, Hansen & Co.

SEC CIK
0000108634
Latest filing
Aug 5, 2026

NVS holding history

Novartis AG in every 13F filed by Wulff, Hansen & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

NVS overviewAll 13F holders of NVSFull Q2 2026 holdings

Shares (Q2 2026)
2,850
Value
$446.7K
% of portfolio
0.3%
Quarters held
19
Since Q4 2021
Holdings of NVS by Wulff, Hansen & Co., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 20262,850$446.7K0.3%−15−0.5%ReducedHolders
Q1 20262,865$437.6K0.4%00.0%UnchangedHolders
Q4 20252,865$395.0K0.3%−60−2.1%ReducedHolders
Q3 20252,925$375.1K0.3%00.0%UnchangedHolders
Q2 20252,925$354.0K0.3%−5−0.2%ReducedHolders
Q1 20252,930$326.6K0.3%−15−0.5%ReducedHolders
Q4 20242,945$286.6K0.3%−100−3.3%ReducedHolders
Q3 20243,045$350.2K0.3%00.0%UnchangedHolders
Q2 20243,045$324.2K0.3%−5−0.2%ReducedHolders
Q1 20243,050$295.0K0.3%−145−4.5%ReducedHolders
Q4 20233,195$322.6K0.4%00.0%UnchangedHolders
Q3 20233,195$325.4K0.4%+250+8.5%AddedHolders
Q2 20232,945$297.2K0.3%00.0%UnchangedHolders
Q1 20232,945$270.9K0.3%−480−14.0%ReducedHolders
Q4 20223,425$310.7K0.4%00.0%UnchangedHolders
Q3 20223,425$260.0K0.3%00.0%UnchangedHolders
Q2 20223,425$290.0K0.3%00.0%UnchangedHolders
Q1 20223,425$301.0K0.3%−745−17.9%ReducedHolders
Q4 20214,170$365.0K0.3%–No prior filingHolders